비뇨의학 Urology Digest ISSN:2713-7910(Print) 2733-5453(Online)

Huggins C et al., Studies on prostate cancer: 1. The effects of castration, of estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate, Cancer Res, 1941

Denmeade SR et al., Bipolar androgen therapy: the rationale for rapid cycling of supraphysiologic androgen ablation in men with castration resistant prostate cancer, Prostate, 2010 10.1002/pros.2119620607766PMC4124628

Xiong X et al., Efficacy and safety of bipolar androgen therapy in mCRPC after progression on abiraterone or enzalutamide: A systemic review, Urol Oncol, 2021

Bipolar androgen-based therapy for prostate cancer (BAT). ClinicalTrials.gov identifier: NCT 01750398, 2012

Teply BA et al., Bipolar androgen therapy in men with metastatic castration resistant prostate cancer after progression on enzalutamide: an open-label, phase 2, multicohort study, Lancet Oncol, 2018 10.1016/S1470-2045(17)30906-3

Sena LA et al., Bipolar androgen therapy sensitizes castration resistant prostate cancer to subsequent androgen receptor ablative therapy, Eur J Cancer, 2021 10.1016/j.ejca.2020.11.04333383350